Long-term effects of tolvaptan in patients requiring recurrent hospitalization for heart failure
Although reports suggest that tolvaptan does not reduce survival or subsequent hospitalization rates in heart failure patients, its continuous use has shown good outcomes in some patients who cannot be effectively managed with high doses of loop diuretics. Therefore, we investigated the association...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Nagoya University
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574322/ |